We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

Actym Therapeutics, a clinical-stage therapeutic product development and platform company, today announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

Food quality matters as much as diet type for heart health. Choosing whole, minimally processed foods can help lower heart ...

Greenlane Renewables Inc. ("Greenlane" or the "Company") , a leading global provider of biogas desulfurization and upgrading systems, today announced that its wholly-owned subsidiary Airdep S.r.l. has ...

Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former ...

I was in Chicago this weekend attending the ASCO meeting, the largest oncology meeting in the world. Nary a talk or poster about "turbo cancer" was seen, but that doesn't mean there wasn't cancer quac ...

BPD may represent an evolutionary mismatch, where traits that were once adaptive have turned maladaptive. Support should ...

I was excited to be road-testing the 2025 Kia Carnival hybrid over the Memorial Day weekend for two reasons. One, I've been ...

In a cleanroom, temperature isn’t just a number but a matter of control. Cleanrooms are high-precision environments, where the slightest fluctuation in temperature can lead to contamination, process ...

By 2025, it is estimated that the worldwide period orthobiologics market will have an estimate of around USD 6,414.4 million.